HomePrevencio Inc.

Prevencio Inc.

New Prevencio Study Using AI Demonstrates Novel Blood Test Accurately Predicts Acute Kidney Injury Risk

11/12/18: In this study, researchers evaluated the company’s AI-driven HART AKI test on 889 patients undergoing cardiac catheterization in Massachusetts General Hospital’s (MGH) Catheter Sampled Blood Archive in Cardiovascular Disease (CASABLANCA) study.

Data Demonstrating HART PAD™ Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients

8/27/18: The study is follow-on to data presented at the American Diabetes Association (ADA) 2018 Scientific Sessions in June 2018 demonstrating Prevencio's HART CAD™ and HART CVE™ tests accurately diagnose coronary artery disease (CAD) and predict the risk for major adverse cardiac events (MACE) in DM patients. Similar to CAD, PAD is commonly due to atherosclerosis, a plaque buildup in the arteries which restricts blood flow.

New Prevencio Study Using AI Demonstrates Simple Blood Test Accurately Diagnoses Aortic Stenosis

3/7/18: Prevencio, Inc., today announces its HARTTM AS multi-protein, artificial intelligence (AI)-driven test, which data indicates accurately diagnoses Aortic Stenosis (AS)—a condition with a 50 percent death rate when left untreated.